Hastina 21

Hastina 21 is a combined oral contraceptive tablet containing the synthetic progestogen drospirenone and the estrogen ethinylestradiol. It is marketed in the European Union and supplied as an oral tablet; the specific strength of each active ingredient is not disclosed in the product label. The medication is prescribed for contraception and menstrual cycle regulation, acting through hormonal mechanisms to prevent ovulation effectively in women of reproductive age.

Hastina 21 is indicated for several hormonal management purposes in women of child‑bearing potential.

- Primary contraception for preventing pregnancy when taken as directed. - Regulation of irregular menstrual cycles and reduction of cycle‑related symptoms. - Management of moderate acne that is responsive to hormonal therapy. - Decrease in the risk of ovarian cyst formation associated with anovulatory cycles. - Treatment of premenstrual dysphoric disorder symptoms in selected patients.

Like other combined oral contraceptives, Hastina 21 may cause a range of side effects, most of which are mild and transient.

Common: - Nausea or mild stomach upset. - Breast tenderness or enlargement. - Headache, including tension‑type. - Spotting or breakthrough bleeding between periods. - Weight fluctuations or fluid retention.

Serious: - Deep vein thrombosis or other blood‑clot events. - Severe hypertension or sudden increase in blood pressure. - Allergic reactions such as rash, itching, or swelling of the face and throat.

Before prescribing Hastina 21, clinicians should evaluate patient history and risk factors to ensure safe use.

- Do not use in women with a history of thromboembolic disorders, stroke, or myocardial infarction. - Avoid if you are pregnant, suspect pregnancy, or are breastfeeding. - Caution in patients with uncontrolled hypertension, diabetes with vascular disease, or liver dysfunction. - Smoking more than 15 cigarettes per day increases cardiovascular risk, especially in women over 35. - Review any personal or family history of hormone‑dependent cancers before initiating therapy. - Consider alternative contraception if you have migraine with aura.

Hastina 21 can interact with several medications, affecting its efficacy or safety profile.

Avoid: - Strong enzyme inducers such as rifampin, carbamazepine, phenytoin, and St John’s wort. - Certain antiviral agents (e.g., efavirenz) that reduce plasma hormone levels. - Antifungal medications like griseofulvin that increase hormone metabolism.

Use with caution: - Anticoagulants (warfarin) – may alter INR values. - Antidiabetic drugs – hormonal changes can affect glucose control. - Seizure medications (phenobarbital) – may require dose adjustment. - Certain antibiotics (e.g., clarithromycin) – may increase hormone concentrations.